We are live on ! Find out more
CLOV icon

Clover Health Investments

178 hedge funds and large institutions have $293M invested in Clover Health Investments in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 62 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $27M | Put options by funds: $12.2M

95% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 20

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

27% more capital invested

Capital invested by funds: $231M → $293M (+$61.4M)

12% more funds holding

Funds holding: 159178 (+19)

2.43% more ownership

Funds ownership: 20.12%22.55% (+2.4%)

Holders
178
Holders Change
+19
Holders Change %
+11.95%
% of All Funds
2.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
62
Reduced
33
Closed
20
Calls
$27M
Puts
$12.2M
Net Calls
+$14.9M
Net Calls Change
+$3.41M
Name Holding Trade Value Shares
Change
Change in
Stake
LOAMU
76
Lombard Odier Asset Management (USA)
New York
$177K +$201K +56,143 New
Pictet Asset Management
77
Pictet Asset Management
Switzerland
$165K
PWM
78
Palacios Wealth Management
Florida
$163K +$149K +41,624 New
CAPTRUST Financial Advisors
79
CAPTRUST Financial Advisors
North Carolina
$156K +$177K +49,567 New
Wells Fargo
80
Wells Fargo
California
$155K -$24.9K -6,976 -12%
Victory Capital Management
81
Victory Capital Management
Texas
$147K -$3.85K -1,076 -2%
TRCT
82
Tower Research Capital (TRC)
New York
$145K +$159K +44,533 +2,868%
XT
83
XTX Topco
Cayman Islands
$143K +$163K +45,537 New
SCP
84
Silverleafe Capital Partners
Tennessee
$142K +$104K +29,091 +183%
NA
85
NewEdge Advisors
Louisiana
$140K +$153K +42,692 +2,248%
SWM
86
SeaCrest Wealth Management
New York
$136K
GAM
87
Gotham Asset Management
New York
$135K -$209K -58,479 -58%
YIH
88
Y-Intercept (HK)
Hong Kong
$135K +$153K +42,829 New
JFG
89
Jefferies Financial Group
New York
$135K +$153K +42,819 New
BP
90
Ballentine Partners
Massachusetts
$131K +$148K +41,496 New
Walleye Capital
91
Walleye Capital
New York
$129K +$146K +40,930 New
State of Wisconsin Investment Board
92
State of Wisconsin Investment Board
Wisconsin
$125K +$29.9K +8,354 +27%
PF
93
Phoenix Financial
Israel
$123K +$8.94K +2,500 +7%
WSFS
94
Wilmington Savings Fund Society
Delaware
$118K
PD
95
Point72 (DIFC)
United Arab Emirates
$116K +$132K +36,800 New
VPIM
96
Vanguard Personalized Indexing Management
California
$114K +$3.38K +945 +3%
DFCM
97
Dark Forest Capital Management
Puerto Rico
$102K +$115K +32,257 New
VCM
98
Viewpoint Capital Management
Washington
$96.1K
TFS
99
Thoroughbred Financial Services
Tennessee
$84K +$95.9K +26,835 New
HSA
100
HBK Sorce Advisory
Pennsylvania
$83.5K +$418 +117 +0.4%

CLOV Hedge Fund Activity: Q4 2024 in Review

178 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2024, worth a combined $293M — up 27% from $231M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CLOV positions and 20 closed out — a net gain of 19 holders — while 62 added to existing stakes and 33 trimmed.

The largest buyer was Marshall Wace, adding an estimated $8.44M. The largest seller was Renaissance Technologies, cutting an estimated $5.05M.

  • 178 institutional investors held Clover Health Investments (CLOV) as of Q4 2024, up from 159 in Q3 2024.
  • Funds reported $293M of Clover Health Investments stock for Q4 2024, up 27% quarter-over-quarter.
  • 39 funds opened new Clover Health Investments positions in Q4 2024 and 20 closed out, a net change of +19 holders.
  • The largest Clover Health Investments buyer in Q4 2024 was Marshall Wace, an estimated $8.44M added.
  • The largest Clover Health Investments seller in Q4 2024 was Renaissance Technologies, an estimated $5.05M sold.

Based on aggregated 13F filings for Q4 2024.